COLA, a physician-directed organization whose purpose is to promote health and safety through accreditation and educational programs, is announcing the hiring of Jeannie St. Pierre as the new Director of Business Development. Jeannie St. Pierre brings with her a wealth of experience in anatomic and clinical pathology laboratories spanning over 25 years.
Jeannie’s impressive career history encompasses a wide range of roles in the healthcare and laboratory industries. Her extensive experience includes holding pivotal positions in operations and sales within major commercial laboratories such as Laboratory Corporation of America and Quest Diagnostics. She has also played a vital role in expanding market share for AmeriPath’s national and regional pathology groups. Her success in these endeavors has been recognized with numerous awards throughout her career, which reflect her remarkable ability to enhance the client experience and streamline internal productivity.
Jeannie St. Pierre’s unique perspective on the laboratory landscape stems from her beginnings in the field, having worked within a laboratory setting at the start of her career. She has since broadened her understanding of the needs and challenges of hospital laboratories through her roles in Hospital Account Management and Business Development. Her keen insights into laboratory dynamics, from the bench to operations, logistics and technology, make her uniquely positioned to drive business growth and foster innovation within COLA.
Nancy Stratton, CEO of COLA, expressed her enthusiasm regarding Jeannie’s addition to the team, stating, “We are pleased to welcome Ms. St. Pierre as our new Director of Business Development. Her extensive experience and comprehensive understanding of the laboratory industry will undoubtedly drive COLA’s continued growth. We welcome her knowledge and expertise.”
Jeannie St. Pierre’s selection as Director of Business Development underscores the organization’s dedication to maintaining high standards in clinical laboratory accreditation.